oral semaglutide phase 3 Type 2 diabetes just got a new front-runner in the race to replace injections with a pill. A head-to-head trial called ACHIEVE-3, presented at the ADA 86th Scientific Sessions and oral semaglutide phase 3 Orforglipron

Consult your physician for more information

You have a personal history of the following conditions: Diabetic retinopathy

Key Takeaways The most common side effects are digestive issues like nausea, diarrhoea, vomiting, and constipation, similar to other GLP-1 medications Some participants experienced mild increases in heart rate at higher doses, but this decreased over time Side effects are typically worse when starting treatment or increasing doses, then improve as your body adjusts Long-term side effects are unknown as trials have only lasted up to one year so far Retatrutide is still in clinical trials and not available for prescription yet By entering I agree to the Terms and Conditions

178 (Suppl

No specific outcomes are guaranteed.